Page last updated: 2024-09-05

n-acetyl-n-formyl-5-methoxykynurenamine and sphingosine

n-acetyl-n-formyl-5-methoxykynurenamine has been researched along with sphingosine in 1 studies

Compound Research Comparison

Studies
(n-acetyl-n-formyl-5-methoxykynurenamine)
Trials
(n-acetyl-n-formyl-5-methoxykynurenamine)
Recent Studies (post-2010)
(n-acetyl-n-formyl-5-methoxykynurenamine)
Studies
(sphingosine)
Trials
(sphingosine)
Recent Studies (post-2010) (sphingosine)
550138,3251173,459

Protein Interaction Comparison

ProteinTaxonomyn-acetyl-n-formyl-5-methoxykynurenamine (IC50)sphingosine (IC50)
ubiquitin-conjugating enzyme E2 NHomo sapiens (human)6.3125
cAMP-dependent protein kinase catalytic subunit alpha Rattus norvegicus (Norway rat)0.098
Sphingosine kinase 2Homo sapiens (human)1.56
Sphingosine kinase 1Homo sapiens (human)3.86

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, X; Meng, P; Qin, W; Tan, G; Wang, H; Wu, H; Yuan, J1

Other Studies

1 other study(ies) available for n-acetyl-n-formyl-5-methoxykynurenamine and sphingosine

ArticleYear
Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.
    Scientific reports, 2017, 04-06, Volume: 7

    Topics: Biomarkers, Tumor; Case-Control Studies; Demography; Female; Humans; Inosine; Kynuramine; Male; Metabolic Networks and Pathways; Metabolomics; Multivariate Analysis; Neoplasm Grading; Principal Component Analysis; Reproducibility of Results; ROC Curve; Sphingosine; Urinary Bladder Neoplasms

2017